FMI is of the opinion that market expansion will continue to come from procedure migration toward minimally invasive surgery, but device demand will still be decided inside the operating room rather than at the patient level. Surgeon familiarity, OR workflow fit, energy platform standardization, and hospital capital budgets remain more influential than marginal product claims when accounts choose or retain suppliers.